Rehabilitation Services for Neurodegenerative Cerebellar Ataxia and Atypical Movement Disorders
Time limit: 180 days
10 credits
Full course description
Johns Hopkins Ataxia Center
presents
Rehabilitation Services for Neurodegenerative Cerebellar Ataxia and Atypical Movement Disorders
Enduring Material: Online content available August 22, 2025 - August 21, 2028
This activity has been approved for AMA PRA Category 1 Credits™.
DESCRIPTION
This 10-hour online enduring material features recorded lectures geared towards Physical Therapists, Occupational Therapists, Speech Language Pathologists, and other allied health professionals who work with patients with non-Parkinson’s Disease movement disorders.
Movement disorders, excluding Parkinson's disease, include cerebellar ataxia, progressive supranuclear palsy, multiple system atrophy, corticobasal syndrome, dementia with Lewy bodies, and Huntington's disease. These conditions affect different areas of the central nervous system, particularly the cerebellum, basal ganglia, and brainstem. Cerebellar ataxia involves uncoordinated limb movements and balance issues, distinct from other disorders like PSP, characterized by eye movement difficulties, or MSA, which affects autonomic and motor functions. HD leads to chorea, involuntary movements, while CBS and DLB have cognitive and motor components.
Physicians use history and clinical exams to differentiate atypical Parkinsonian syndromes from idiopathic PD. Red flags include rapid progression, early autonomic dysfunction, and cognitive changes. Abnormal limb movements, e.g., tremors, bradykinesia, chorea and eye movements, such as saccadic issues in PSP help in diagnosis. Cerebellar ataxia typically presents with wide-based gait and incoordination, distinguishing it from other disorders.
Physical therapy, occupational therapy, and speech-language pathology play key roles in managing movement disorders. Standardized assessments include motor function tests, e.g., Berg Balance Scale for PT, and cognitive-linguistic evaluations for SLP. Therapy strategies focus on functional improvement and compensatory techniques for maintaining independence.
WHO SHOULD ENROLL
This activity is intended for physicians, physical therapists, occupational therapists, speech language therapists, and other allied health professionals.
OBJECTIVES
After participating in this activity, the learner will demonstrate the ability to:
-
Identify the similarities and differences between how each of the non-PD neurodegenerative disorders present.
-
Explain the similarities and differences regarding the assessment and evaluation for each of the non-PD neurodegenerative disorders.
-
Implement the different approaches to the variety of non-PD neurodegenerative disorders.
ACCREDITATION STATEMENTThe Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. |
 |
CREDIT DESIGNATION STATEMENT
The Johns Hopkins University School of Medicine designates this enduring material activity for a maximum of 14.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
POLICY ON PRESENTER AND PROVIDER DISCLOSURE
It is the policy of the Johns Hopkins School of Medicine that the presenter and provider globally disclose conflicts of interest. The Johns Hopkins School of Medicine OCME has established policies in place to identify and mitigate relevant conflicts of interest prior to this educational activity. Detailed disclosure will be made prior to presentation of the education.
Other credits
American Academy of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 CreditTM from organizations accredited by the ACCME.
This program is offered for 1.0 CEUs, (various level). ASHA CE Provider approval does not imply endorsement of course content, specific products or clinical procedures. ASHA Credits are approved through May 31, 2026.
This continuing education has been approved by the Maryland State Board of Physical Therapy Examiners for 10 Continuing Education Hours.
National Commission on Certification of Physician Assistants PAs may claim a maximum of 10 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
The Johns Hopkins University has approved this activity for 10 contact hours for non-physicians.
NOTICE ABOUT OFF-LABEL USE PRESENTATIONS
The Johns Hopkins School of Medicine/ Rehabilitation Services for Neurodegenerative Cerebellar Ataxia and Atypical Movement Disorders may include presentations on drugs or devices, or use of drugs or devices, that have not been approved by the Food and Drug Administration (FDA) or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or device he or she wishes to use in clinical practice.
The Johns Hopkins School of Medicine is committed to the free exchange of medical education. Inclusion of any presentation in this program, including presentations on off-label uses, does not imply an endorsement by Johns Hopkins of the uses, products, or techniques presented.
PERSONALLY PROVIDED INFORMATION (PPI) POLICY
The Johns Hopkins School of Medicine Office of Continuing Medical Education (OCME) is committed to protecting the privacy of its members and customers. If you choose to provide us with personal information by sending an email, or by filling out a form with your personal information and submitting it through our Web site, we use that information to respond to your message and to help us provide you with information, products, or services that you request. We do not give, share, sell, or transfer any personal information to a third party unless required by law. The complete University privacy policy may be accessed via the OCME Web site.
Upon request, OCME will email you information for upcoming activities relevant to your interests. You may unsubscribe at any time.
JOHNS HOPKINS STATEMENT OF RESPONSIBILTY
The Johns Hopkins School of Medicine takes responsibility for the content, quality and scientific integrity of this CME activity.
COPYRIGHT INFORMATION
All rights reserved - The Johns Hopkins School of Medicine. No part of this program may be used or reproduced in any manner whatsoever without written permission except in the case of brief quotations embodied in articles or reviews.
DISCLAIMER STATEMENT
The opinions and recommendations expressed by faculty and other experts whose input is included in this activity are their own. This enduring material is produced for educational purposes only. Use of Johns Hopkins School of Medicine name implies review of educational format design and approach. Please review the complete prescribing information and safety profile of specific drugs or combination of drugs, including indications, contraindications, warnings, and adverse effects before administering pharmacologic therapy to patients.
FULL DISCLOSURE POLICY AFFECTING CME ACTIVITIES
As a provider approved by the Accreditation Council for Continuing Medical Education (ACCME), Johns Hopkins University School of Medicine Office of Continuing Medical Education (OCME) requires attested and signed global disclosure of the existence of all financial interests or relationships with ineligible companies from any individual in a position to control the content of a CME activity sponsored by OCME.
The following relationships have been reported for this activity:
| NAME | ROLE | RELATIONSHIPS |
| Weiyi Mu, ScM | Presenter |
Consulting Fee: UCB BioPharma SRL |
| Alexander Pantelyat, MD | Presenter |
Advisor: Biosensics
Consulting Fee: Ferrer International
Membership on Advisory Committees or Review Panels, Board Membership, etc.: MedRhythms, Inc., Ono Pharma |
| Liana Rosenthal, MD, PhD | Planner/ Presenter |
Consulting Fee: Bial Biotech, Biogen, Biohaven, Reata, UCB Pharma
Grant or research suport: Biohaven, EIP Pharma, Functional Neuromodulation, Pfizer, Inc. |
No one else in a position to control the content of this educational activity has disclosed a relevant financial interest or relationship with ineligible companies.
All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
Note: Grants to investigators at the Johns Hopkins University are negotiated and administered by the institution which receives the grants, typically through the Office of Research Administration. Individual investigators who participate in the sponsored project(s) are not directly compensated by the sponsor, but may receive salary or other support from the institution to support their effort on the project(s).
CONFIDENTIALITY DISCLAIMER FOR CME ACTIVITIES
The I certify that I am participating in a Johns Hopkins University School of Medicine CME activity for accredited training and/or educational purposes.
I understand that while I am participating in this capacity, I may be exposed to "protected health information," as that term is defined and used in Hopkins policies and in the federal HIPAA privacy regulations (the "Privacy Regulations"). Protected health information is information about a person's health or treatment that identifies the person.
I pledge and agree to use and disclose any of this protected health information only for the training and/or educational purposes of my visit and to keep the information confidential. I agree not to post or discuss this protected health information, including pictures and/or videos, on any social media site (e.g. Facebook, Twitter, etc.), in any electronic messaging program or through any portable electronic device.
I understand that I may direct to the Johns Hopkins Privacy Office any questions I have about my obligations under this Confidentiality Pledge or under any of the Hopkins policies and procedures and applicable laws and regulations related to confidentiality. The contact information is: Johns Hopkins Privacy Office, telephone: 410-614-9900, e-mail.
LIST OF TALKS
- Course Introduction
- Overview of non-PD movement disorders
- Pharmacology
- Abnormal eye movements
- Genetics of non-PD movement disorders
- Neuropsychology approach
- Rehab management - PT
- Treatment principles
- Rehab management - OT
- Treatment principles
- Rehab management - SLP
- Treament principles
For a detailed information, please visit review the agenda: Rehabilitation Services for Neurodegenerative Cerebellar Ataxia
REGISTRATION
Method of Payment: Learners must register and submit full payment prior to the start of the activity. The registration fee includes access to the online content and downloadable instructional materials.
You will receive a confirmation by email from Instructure. If you have not received it within 24 hours of registering, email the Office of Online Education to confirm that you are registered.
The Johns Hopkins University reserves the right to cancel or postpone any activity due to unforeseen circumstances. In this event, the University will refund the registration fee. Under such circumstances registrants will be notified as soon as possible.
REFUND POLICY
Refunds will only be issued for learners who have not accessed the course.
SYLLABUS/INSTRUCTIONAL MATERIALS
All online content will be accessible via canvas.jhu.edu once you have registered.
COURSE FORMAT - METHOD OF PARTICIPATION
This enduring material is expected to take approximately 10.0 hours to complete. Once the activity is completed, you must pass the post-test and complete the evaluation with attestation to receive CME credit.
HOW TO OBTAIN CREDIT
CME credit for this course will be issued through the central CME system for Johns Hopkins, CloudCME. Once a learner has completed the course, their CME transcript will be udpated within 7 business days and can be accessed at https://hopkinscme.cloud-cme.com/. The last day to access the evaluation and attest to your credits is September 21, 2028.
RELEASE DATE
August 22, 2025
EXPIRATION DATE
August 21, 2028
PREREQUISITES FOR PARTICIPANTS
There are no prerequisites to participate in this activity.
TECHNICAL PREREQUISITES
The course will take place on the Canvas LMS (Canvas.jhu.edu). You will need the ability to log on to the platform, preferably using Google Chrome, to complete the content, which will include videos, readings, and assignments. You may also need to take part in other activities on Canvas.jhu.edu.
- Hardware requirements: computer; webcam; microphone and speakers or headset.
- Software requirements: Google Chrome web browser; access to Canvas.jhu.edu; Zoom web conferencing; Microsoft Office or similar; email
EVALUATION AND OUTCOMES SURVEY
Post activity, an online evaluation form will be available to attendees to evaluate the activity and identify future educational needs. Upon completion of the evaluation, the learner must attest to the number of hours in attendance. A certificate of attendance will be available immediately for download or print. The last day to evaluate the material and attest to your credits is October 5, 2028.
POST-TEST
A post-test will be conducted at the conclusion of the activity. A grade of at least 70% within three attempts is needed to receive CME credit.
AMERICANS WITH DISABILITIES ACT
The Johns Hopkins School of Medicine fully complies with the legal requirements of the ADA and the rules and regulations thereof. Please notify us if you have any special needs.
FOR FURTHER INFORMATION
Office of CME: Email
Organization Code: HopkinsCME
For technical assistance with CloudCME or credits, please visit our tech support help page: https://hopkinscme.cloud-cme.com/about/help.
For technical assistant with the course, Canvas.jhu.edu, or learnmore.jhu.edu, please email the Office of Online Education.